QO_Q3_2019_1024x768_Dembik
Quarterly Outlook

Europe’s green relocation dream

Christopher Dembik
Head of Macroeconomic Research

Summary:  It is essential to adopt a coordinated European approach to reduce the inherent costs associated with relocation. The least we can say is that Europe is not heading in this direction.

The coronavirus pandemic has highlighted Europe’s overdependence on Asia, particularly China and India, for the production of medical equipment and devices (e.g. hydroalcoholic gel, masks and resuscitation respirators) as well as the active ingredients that are key components of commonly used drugs. While in the 1980s and 1990s, around 60% of all active ingredients were of European origin, the situation was completely reversed from 2010 with China and India now jointly accounting for up to 60% of total production.  

The crisis served as a wake-up call to European governments and society on the urgent need to diminish economic and health dependence on the rest of the world. Emmanuel Macron called for “European and national sovereignty” and “full independence” for parts of the medical markets. Others, certainly inspired by Japan’s financial incentives to move Japanese companies’ production out of China, went further with this idea and asked for an European industrial policy that would aim to relocate as many economic activities as possible in Europe. 

Reshoring of value chains is not a new idea; it is as old as globalisation itself. But it has swung back into fashion in recent years on the back of rising protectionism – and it has gained more ground over the past few months due to the outbreak. From Trump’s 2016 campaign to UK manufacturing’s campaign today in favor of “aggressive” reshoring of supply chains in the UK, there is an underlying belief that if more products and goods are produced at home, the economy will turn better.  

In theory, relocation is a very attractive idea. It should bring many advantages: reindustrialisation, creation of new jobs, limiting supply chain disruption in the event of a new external shock similar to the virus and, above all, environmental sustainability. But the question is whether Europe has the means to realise its ambitions and become more self-reliant. 

The euro-area balance of trade provides us with initial answers. It shows the difference between sales and purchases made abroad and is used to assess relative import/export dependence to the rest of the world.  

Euro-area trade is characterised by a massive surplus, mostly due to Germany reaching a EUR 338-billion surplus in the twelve-month period to March 2020, which represents roughly 2.8% of euro-area GDP. This is the second biggest trade surplus in the world, behind China. Europeans, then, are selling more abroad (outside the Union) than they buy. The EU open trade regime is therefore marked by a strong reliance on exports and lesser import dependence – which means that the EU is broadly self-sufficient, notably in most primary agricultural commodities. 

That being said, can it regain autonomy in goods and products where it is not self-sufficient yet, such as medical equipment or printed circuit boards that are essential to smartphones and computer production? It is highly uncertain.  

Even if it can regain autonomy, relocation is far from the miracle solution that many claim it to be. At the very least, it requires resources, skills, leadership and a tolerance for higher costs – and that’s not even considering potential retaliation from China. It assumes that host countries have the requisite workforce and know-how, which is not always the case for manufacturing many products and goods.  

Creating a vibrant industrial base requires long-term vision, political leadership and the capacity to work hand-in-hand with the private sector. Relocation cannot be decreed, it is built over time. It involves long and risky processes – including reorganising value chains, which can take years.  

Plus, as we all know, there is no free lunch in economics. Reshoring usually leads to higher costs for businesses that are almost systematically passed to consumers. Thus, it is essential to adopt a coordinated European approach to create economies of scale and reduce, as much as possible, the inherent costs associated with relocation. The least we can say is that Europe is not heading in this direction.  

In the context of the seven-year MFF negotiations and “Next Generation EU” instrument, the European Commission has proposed to boost Horizon Europe – an already existing programme that is aimed at strengthening autonomy in strategic value chains, among other things.  

If validated by the European Council, the total envelope could reach EUR 94.4 billion over the period 2021-2027, versus EUR 80.9 billion initially. So the package allocated to reduce EU reliance on outside trade would represent, at best, 0.08% of EU GDP per year. Even considering other programmes, such as those targeting climate change impact and aiming to develop new industrial clusters, this is a mere drop in the ocean. The EU’s ambition to become more self-sufficient is nothing but empty promises.  

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.